Table 1.
Comparison of basic and clinical indicators between the 2 groups
| Item | Control group (n = 199) | Case group (n = 117) |
P value |
|---|---|---|---|
| Age (yr) | 29.410 ± 4.803 | 31.460 ± 5.253 | <0.001 |
| HCY (μmol/L) | 10.600(6.600–14.800) | 14.000(10.100,18.900) | <0.001 |
| Height (cm) | 161.580 ± 4.855 | 161.210 ± 4.434 | 0.497 |
| Weight (kg) | 74.299 ± 9.257 | 79.914 ± 10.076 | <0.001 |
| UA (μmol/L) | 275.820 ± 72.209 | 350.040 ± 94.962 | <0.001 |
| CYC (mg/L) | 1.081 ± 0.289 | 1.376 ± 0.339 | <0.001 |
| TBA (μmol/L) | 2.100(1.400–3.200) | 3.400(1.500–5.100) | <0.001 |
| Calcium (mmol/L) | 2.148 ± 0.103 | 2.081 ± 0.223 | 0.003 |
| BMI (kg/m2) | 28.457 ± 3.348 | 30.766 ± 3.793 | <0.001 |
| Zinc (μmol/L) | 8.248 ± 1.599 | 7.727 ± 1.972 | 0.016 |
| Albumin (g/L) | 33.360 ± 4.136 | 29.997 ± 3.911 | <0.001 |
| Globulin (g/L) | 25.175 ± 3.618 | 24.553 ± 3.275 | 0.128 |
| WBC (109/L) | 10.068 ± 2.487 | 10.698 ± 3.174 | 0.069 |
| RBC (109/L) | 3.743 ± 0.411 | 3.756 ± 0.565 | 0.796 |
| HB(g/L) | 105.620 ± 14.201 | 109.220 ± 17.550 | 0.062 |
| PLT (109/L) | 221.810 ± 61.384 | 218.670 ± 69.487 | 0.678 |
| DBil (μmol/L) | 2.400(1.900–3.200) | 2.400(1.900–3.050) | 0.562 |
| IBil (μmol/L) | 2.750(1.770–4.000) | 2.200(1.400–3.900) | 0.090 |
| FFA (mmol/L) | 0.460(0.340–0.610) | 0.490(0.350–0.640) | 0.594 |
| Glu (mmol/L) | 4.740 ± 1.408 | 5.050 ± 1.292 | 0.061 |
| FH (yes/no) | 64.8%/28.6% | 35.2%/71.4% | 0.090 |
| EGFR (ml/min/1.73 m2) | 222.933 ± 66.143 | 187.506 ± 58.359 | <0.001 |
HCY Homocysteine, UA Uric acid, CYC Cysteine, TBA Total bile acid, BMI Body mass index, EGFR Estimated glomerular filtration rate, WBC White blood cell count, RBC Red blood cell count, HB Hemoglobin, PLT Platelets, DBil Direct bilirubin, IBil Indirect bilirubin, FFA Free fatty acids, Glu Glucose, FH Family history